Benzodiazepine Guide for Personal Injury Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 10 min read

A comprehensive guide to benzodiazepines prescribed in personal injury -- alprazolam, lorazepam, diazepam, clonazepam -- covering DEA scheduling, duration of action, abuse risk management, and what benzodiazepine prescriptions signal for PI case documentation and general damages.

Benzodiazepines are a class of psychoactive medications that enhance the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, producing anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. In personal injury cases, benzodiazepines are prescribed for acute anxiety, panic disorder, PTSD-related hyperarousal, and muscle spasm -- and their presence in the pharmacy record documents psychological and neuromuscular injury consequences that directly support general damages claims.

• Benzodiazepines are DEA Schedule IV controlled substances prescribed for anxiety, panic disorder, PTSD symptoms, and muscle spasm after traumatic injury
• Four benzodiazepines commonly appear in PI pharmacy records: alprazolam (Xanax), lorazepam (Ativan), diazepam (Valium), and clonazepam (Klonopin)
• Their presence documents psychiatric and psychological injury consequences beyond physical pain, directly supporting general damages
• Current prescribing guidelines limit benzodiazepine duration due to dependence risk, making their continued prescription particularly strong evidence of severe, ongoing psychological distress
• LienScripts documents all benzodiazepine prescriptions through its pharmacy lien program, capturing the full psychiatric medication timeline

Why Benzodiazepines Are Prescribed After Traumatic Injury

Traumatic injury -- particularly motor vehicle accidents, pedestrian strikes, and violent incidents -- produces psychological consequences that frequently require pharmacological intervention:

Acute anxiety and panic. Accident survivors commonly develop acute anxiety with panic attacks triggered by driving, riding in vehicles, or situational reminders of the accident. The sudden onset of these symptoms after a previously non-anxious individual's traumatic experience directly links the anxiety to the injury event.

PTSD-related hyperarousal. Post-traumatic stress disorder produces a state of chronic nervous system hyperactivation characterized by exaggerated startle responses, hypervigilance, irritability, and difficulty concentrating. While SSRIs are the first-line treatment for PTSD, benzodiazepines may be prescribed for acute hyperarousal episodes.

Muscle spasm with anxiety component. Diazepam has both anxiolytic and muscle relaxant properties, making it uniquely appropriate for PI patients whose muscle spasm is exacerbated by anxiety-driven muscle tension.

Sleep disruption from anxiety. When anxiety prevents sleep initiation or causes middle-of-night awakenings with racing thoughts, benzodiazepines may be prescribed as short-term adjuncts to primary sleep medications.

Comprehensive Comparison: All Benzodiazepines in PI Practice

When Physicians Prescribe Each Agent

Alprazolam: Panic Disorder and Acute Anxiety

Alprazolam is the most commonly prescribed benzodiazepine in PI cases. Its rapid onset and intermediate duration make it appropriate for the acute panic attacks and situational anxiety that accident survivors experience. The typical prescription is 0.25-0.5 mg two to three times daily as needed.

In PI documentation, alprazolam prescriptions confirm that the treating physician or psychiatrist diagnosed an anxiety disorder severe enough to warrant controlled-substance treatment. Each fill date provides timestamped evidence that the anxiety was ongoing at that point in the case timeline.

Lorazepam: Acute Anxiety and Procedural Use

Lorazepam is frequently the first benzodiazepine encountered in PI pharmacy records because it is commonly prescribed in emergency departments and hospitals during the acute post-injury period. It has no active metabolites (unlike diazepam), making it safer for patients with liver compromise from injury or concurrent medications.

Its presence early in the pharmacy record documents that the patient's anxiety was severe enough to require benzodiazepine treatment in the acute care setting -- before the patient even reached outpatient follow-up.

Diazepam: Combined Muscle Spasm and Anxiety

Diazepam occupies a unique position among benzodiazepines because it provides both anxiolytic and muscle relaxant effects. In PI cases, it is prescribed when the patient presents with anxiety-driven muscle tension superimposed on traumatic muscle spasm. Its long half-life (20-100 hours including active metabolites) provides sustained coverage.

Its prescription documents a clinical assessment that the patient's musculoskeletal symptoms and psychological symptoms are intertwined -- the anxiety is worsening the muscle spasm, and both require simultaneous treatment.

Clonazepam: Chronic Anxiety and PTSD

Clonazepam has the longest effective duration among the commonly prescribed benzodiazepines, making it appropriate for sustained anxiety management rather than acute episodic treatment. In PI cases, it is typically prescribed by psychiatrists for chronic PTSD-related anxiety when SSRIs alone are insufficient.

Its presence in the pharmacy record documents a chronic psychiatric condition requiring ongoing pharmacological management -- not a brief reactive anxiety that resolved quickly.

Risks, Guidelines, and Documentation Implications

Modern prescribing guidelines recommend limiting benzodiazepine use to the shortest effective duration due to risks of:

• Physical dependence (tolerance and withdrawal)
• Cognitive impairment
• Falls (particularly in elderly patients)
• Respiratory depression (particularly with concurrent opioid use)

This prescribing caution makes benzodiazepine documentation more valuable, not less. When a physician prescribes or continues a benzodiazepine in today's regulatory environment, they have made a clinical judgment that the patient's anxiety or psychological distress is severe enough to warrant accepting these risks. The physician's willingness to prescribe -- and continue prescribing -- a benzodiazepine is a documented clinical determination of symptom severity.

Treatment Escalation Patterns and PI Documentation Value

Benzodiazepine prescribing patterns in PI cases reveal the trajectory of psychological injury:

• No psychiatric medication to benzodiazepine -- New-onset anxiety/panic following traumatic event; causal link to accident
• As-needed (PRN) to scheduled dosing -- Anxiety episodes becoming frequent enough to require regular prophylaxis
• Short-acting (alprazolam) to long-acting (clonazepam) -- Sustained anxiety requiring continuous coverage; condition becoming chronic
• Benzodiazepine alone to benzodiazepine + SSRI -- Long-term treatment transition; SSRI for maintenance, benzodiazepine for acute breakthrough
• Benzodiazepine taper -- Clinical improvement; physician-managed gradual dose reduction documenting recovery timeline
• Benzodiazepine replaced by non-benzodiazepine anxiolytic -- Transition to hydroxyzine or buspirone; long-term management after acute phase

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist with clinical experience in psychiatric pharmacy, explains, "Benzodiazepine prescriptions in PI cases document something that no other medication class can: the physician's determination that the patient's psychological distress is severe enough to warrant a controlled substance with known dependence potential. In the current prescribing environment, this is not a casual clinical decision -- it is a documented threshold of psychiatric severity."

Defense Challenges and Rebuttals

"The patient had anxiety before the accident"

Rebuttal: The pharmacy record establishes temporal causation. If no benzodiazepine prescriptions exist before the accident and new prescriptions begin afterward, the anxiety onset is documented. If pre-existing anxiety existed, the new prescription or dose escalation documents worsening -- the aggravation doctrine requires the defendant to compensate for the aggravation.

"Benzodiazepines are over-prescribed and do not reflect genuine injury"

Rebuttal: Current prescribing guidelines actually restrict benzodiazepine use due to dependence concerns, making physicians cautious about prescribing them. The treating physician or psychiatrist determined that the patient's anxiety was severe enough to warrant a controlled substance despite these known risks. This represents a high threshold of clinical severity, not casual prescribing.

"The patient should use non-medication approaches for anxiety"

Rebuttal: Non-pharmacological interventions (cognitive behavioral therapy, mindfulness, relaxation techniques) are appropriate adjuncts but are not sufficient for severe acute anxiety, panic disorder, or PTSD-related hyperarousal that significantly impairs daily function. The physician's decision to prescribe pharmacological treatment documents that the psychological injury exceeded what behavioral interventions alone could manage.

MERIT Documentation for Benzodiazepine Cases

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. For cases involving benzodiazepines, the MERIT report documents the psychiatric medication timeline alongside pain medications and antidepressants, creating a comprehensive pharmaceutical record that demonstrates both the physical and psychological dimensions of the traumatic injury.